N-TERT.-BUTYLOXYCARBONYL-2-AMINO-ACETIC-ACID-[3-(1,3-DIHYDRO-1,3-DIOXO-2H-ISOINDOLE-2-YL)-2,6-DIOXO-PIPERIDINE-1-YL-METHYL]-ESTER
Compound with spectra: 1 NMR
![N-TERT.-BUTYLOXYCARBONYL-2-AMINO-ACETIC-ACID-[3-(1,3-DIHYDRO-1,3-DIOXO-2H-ISOINDOLE-2-YL)-2,6-DIOXO-PIPERIDINE-1-YL-METHYL]-ESTER](/api/compound/BciN00c76RK.png?ph=true&h=300&w=458 "N-TERT.-BUTYLOXYCARBONYL-2-AMINO-ACETIC-ACID-[3-(1,3-DIHYDRO-1,3-DIOXO-2H-ISOINDOLE-2-YL)-2,6-DIOXO-PIPERIDINE-1-YL-METHYL]-ESTER")
| SpectraBase Compound ID | BciN00c76RK |
|---|---|
| InChI | InChI=1S/C21H23N3O8/c1-21(2,3)32-20(30)22-10-16(26)31-11-23-15(25)9-8-14(19(23)29)24-17(27)12-6-4-5-7-13(12)18(24)28/h4-7,14H,8-11H2,1-3H3,(H,22,30) |
| InChIKey | HDSZLXLOSUKBBZ-UHFFFAOYSA-N |
| Mol Weight | 445.43 g/mol |
| Molecular Formula | C21H23N3O8 |
| Exact Mass | 445.148515 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
2-(AMINOACETYLAMINO)-ACETIC-ACID-[3-(1,3-DIHYDRO-1,3-DIOXO-2H-ISOINDOLE-2-YL)-2,6-DIOXO-PIPERIDINE-1-YL-METHYL]-ESTER-HCL
SUCCINIC-ACID-MONO-[3-(1,3-DIHYDRO-1,3-DIOXO-2H-ISOINDOLE-2-YL)-2,6-DIOXO-PIPERIDINE-1-YL-METHYL]-ESTER
2-METHYLAMINO-(PROPIONIC-ACID)-[3-(1,3-DIHYDRO-1,3-DIOXO-2H-ISOINDOLE-2-YL)-2,6-DIOXO-PIPERIDINE-1-YL-METHYL]-ESTER-HCL
[3-(1,3-DIHYDRO-1,3-DIOXO-2H-ISOINDOLE-2-YL)-2,6-DIOXO-PIPERIDINE-1-YL]-ACETIC-ACID-TERT.-BUTYLESTER
(.alpha.R,3R)N-(2-Hydroxy-1-phenylethyl)-3-phthalimidopiperidin-2-one
(S/R)-2-Phthaloylamidopent-4-enoic acid [(2S)-methoxycarbonylpyrrolidinyl]amide
1,3-dioxo-alpha-{2-[(6-ethoxy-2-benzothiazolyl)carbamoyl]ethyl}-2-isoindolineacetic acid
2-{[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-3-phenylpropanoyl]amino}benzoic acid
6'-Deoxy-4'-tert-butyldimethylsilyloxythalidomide
Methylthalidomide ME
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis and immunological activity of water-soluble Thalidomide prodrugs | Bioorganic & Medicinal Chemistry | 2001 |